左甲状腺素治疗者正常范围内甲状腺功能变异与能量消耗及体成分的关系
本研究为横断面研究,纳入140例接受左甲状腺素(L-T4)替代治疗且促甲状腺激素(TSH)水平覆盖实验室参考范围(0.34至5.6 mU/L)的健康甲状腺功能减退受试者,检测能量消耗、底物氧化、饮食摄入和体成分。结果发现低正常(≤2.5 mU/L)与高正常(>2.5 mU/L)TSH组各项结局指标无差异,但血清游离三碘甲状腺原氨酸(fT3)水平与静息能量消耗、体质指数(BMI)、体脂量和内脏脂肪量直接相关,且这些变化具有临床相关性。结论认为在L-T4治疗者中,甲状腺功能在实验室参考范围内的变异与静息能量消耗、BMI和体成分具有临床相关性的关联,但fT3较高对能量消耗的有利效应可能被对体重和体成分的不利效应所抵消,需进一步研究后才能将这些结局作为调整L-T4剂量的依据。
要点
- 低正常TSH(≤2.5 mU/L)与高正常TSH(>2.5 mU/L)组各项结局指标无差异。
- 血清fT3水平与静息能量消耗、BMI、体脂量和内脏脂肪量直接相关。
- fT3较高对能量消耗的有利效应可能被对体重和体成分的不利效应抵消。
核心结论
- 在L-T4治疗者中,甲状腺功能在实验室参考范围内的变异与静息能量消耗、BMI和体成分具有临床相关性的关联。
- fT3较高对能量消耗的有利效应可能被对体重和体成分的不利效应所抵消。
- 需进一步研究后才能将这些结局作为调整L-T4剂量的依据。
研究设计与样本
- 横断面研究,纳入140例接受慢性左甲状腺素(L-T4)替代治疗且其他方面健康的甲状腺功能减退受试者,TSH水平覆盖实验室参考范围(0.34至5.6 mU/L)。
- 受试者接受能量消耗(总能量消耗、静息能量消耗、食物热效应、体力活动能量消耗)、底物氧化、饮食摄入和体成分的详细检测。
主要发现
- 低正常TSH(≤2.5 mU/L)与高正常TSH(>2.5 mU/L)组在任何结局指标上均无差异。
- 在整个研究组中,血清游离三碘甲状腺原氨酸(fT3)水平与静息能量消耗、体质指数(BMI)、体脂量和内脏脂肪量直接相关,且这些结局的变化具有临床相关性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究后才能将这些结局作为调整L-T4剂量的依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: It is not clear whether upper limits of the thyrotropin (TSH) reference range should be lowered. This debate can be better informed by investigation of whether variations in thyroid function within the reference range have clinical effects. Thyroid hormone plays a critical role in determining energy expenditure, body mass, and body composition, and therefore clinically relevant variations in these parameters may occur across the normal range of thyroid function. METHODS: This was a cross-sectional study of 140 otherwise healthy hypothyroid subjects receiving chronic replacement therapy with levothyroxine (L-T4) who had TSH levels across the full span of the laboratory reference range (0.34 to 5.6 mU/L). Subjects underwent detailed tests of energy expenditure (total and resting energy expenditure, thermic effect of food, physical activity energy expenditure), substrate oxidation, diet intake, and body composition. RESULTS: Subjects with low-normal (≤2.5 mU/L) and high-normal (>2.5 mU/L) TSH levels did not differ in any of the outcome measures. However, across the entire group, serum free triiodothyronine (fT3) levels were directly correlated with resting energy expenditure, body mass index (BMI), body fat mass, and visceral fat mass, with clinically relevant variations in these outcomes. CONCLUSIONS: Variations in thyroid function within the laboratory reference range have clinically relevant correlations with resting energy expenditure, BMI, and body composition in L-T4-treated subjects. However, salutary effects of higher fT3 levels on energy expenditure may be counteracted by deleterious effects on body weight and composition. Further studies are needed before these outcomes should be used as a basis for altering L-T4 doses in L-T4-treated subjects.
引用
- Samuels MH, Kolobova I, Antosik M, et al. Thyroid Function Variation in the Normal Range, Energy Expenditure, and Body Composition in L-T4-Treated Subjects. J Clin Endocrinol Metab. 2017. PMID: 28460140. doi:10.1210/jc.2017-00224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。